Effectiveness and Safety of Secukinumab in Latin American Patients with Moderate to Severe Plaque Psoriasis: PURE Registry 12-Month Data.

ABSTRACT:

Background

 The efficacy and safety of secukinumab in patients with psoriasis has been established in randomised clinical trials. However, data on effectiveness and safety of secukinumab in Latin American real-world settings are scarce.

Objectives

To evaluate the effectiveness and safety of secukinumab in real-world settings in patients with psoriasis in Latin America.

Methods

PURE is an ongoing multinational, prospective, observational study in patients with moderate-to-severe chronic plaque psoriasis in Canada and Latin America assessing the real-world safety and effectiveness of secukinumab and other approved therapies. The study enrolled (1:1) patients treated with secukinumab versus other approved therapies (other Tx) per local standard of care from 81 community-

SUBMITTER: Papp KA 

PROVIDER: S-EPMC9823177 | biostudies-literature | 2023 Jan

REPOSITORIES: biostudies-literature